These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
418 related articles for article (PubMed ID: 28606264)
1. [The value of DCE-MRI in assessing the course of thyroid associated ophthalmopathy]. Wu T; Tang DR; Wang F; Xia S; Sun FY Zhonghua Yan Ke Za Zhi; 2017 Jun; 53(6):430-435. PubMed ID: 28606264 [No Abstract] [Full Text] [Related]
2. Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity. Jiang H; Wang Z; Xian J; Li J; Chen Q; Ai L Acta Radiol; 2012 Feb; 53(1):87-94. PubMed ID: 22184678 [TBL] [Abstract][Full Text] [Related]
3. Quantitative evaluation of activity of thyroid-associated Ophthalmopathy using short-tau inversion recovery (STIR) sequence. Ge Q; Zhang X; Wang L; Fan Y; Huang Q; Yao N; Long J; Liu C BMC Endocr Disord; 2021 Nov; 21(1):226. PubMed ID: 34774035 [TBL] [Abstract][Full Text] [Related]
4. Correlation between extent of lacrimal gland prolapse and clinical features of thyroid-associated ophthalmopathy: a retrospective observational study. Gao Y; Chang Q; Li Y; Zhang H; Hou Z; Zhang Z; Li Z; Li D BMC Ophthalmol; 2022 Feb; 22(1):66. PubMed ID: 35144579 [TBL] [Abstract][Full Text] [Related]
5. Fractional anisotropy and diffusivity changes in thyroid-associated orbitopathy. Han JS; Seo HS; Lee YH; Lee H; Suh SI; Jeong EK; Sapkota N; Kim KJ Neuroradiology; 2016 Dec; 58(12):1189-1196. PubMed ID: 27844093 [TBL] [Abstract][Full Text] [Related]
6. [Clinical application of orbital scintigraphy with 99Tc(m)-octreotide in patients with thyroid associated ophthalmopathy]. Duan L; Li XF; Lu KY; Zhang CG; Hu G; Liu JZ; Li SJ Zhonghua Yan Ke Za Zhi; 2006 Dec; 42(12):1068-72. PubMed ID: 17415962 [TBL] [Abstract][Full Text] [Related]
7. ROLE OF MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY PATIENTS WITH LONG DISEASE DURATION. Zhou M; Shen L; Jiao Q; Ye L; Zhou Y; Zhu W; Wang W; Wang S Endocr Pract; 2019 Dec; 25(12):1268-1278. PubMed ID: 31412229 [No Abstract] [Full Text] [Related]
8. Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance. Chen L; Hu H; Chen HH; Chen W; Wu Q; Wu FY; Xu XQ Br J Radiol; 2021 Feb; 94(1118):20200884. PubMed ID: 33353397 [TBL] [Abstract][Full Text] [Related]
9. Quantitative Analysis of Inflammation in Orbital Fat of Thyroid-associated Ophthalmopathy Using MRI Signal Intensity. Higashiyama T; Iwasa M; Ohji M Sci Rep; 2017 Dec; 7(1):16874. PubMed ID: 29203853 [TBL] [Abstract][Full Text] [Related]
10. T2 Relaxation Time in Extraocular Muscles of Patients with Mild Thyroid- Associated Ophthalmopathy: Comparing T2 Mapping With and Without Fat Suppression Using Different Measurement Methods. Li D; Guo X; Zeng J; Feng H; Zhu T; Li H Curr Med Imaging; 2024; 20():e15734056299907. PubMed ID: 38639286 [TBL] [Abstract][Full Text] [Related]
11. Quantitative T1 mapping MRI for the assessment of extraocular muscle fibrosis in thyroid-associated ophthalmopathy. Ma R; Geng Y; Gan L; Peng Z; Cheng J; Guo J; Qian J Endocrine; 2022 Feb; 75(2):456-464. PubMed ID: 34549377 [TBL] [Abstract][Full Text] [Related]
12. Evaluating the Microcirculation of Normal Extraocular Muscles Using Quantitative Dynamic Contrast-Enhanced Magnetic Resonance Imaging. Guo Y; Huo L; Wang P; Huang L; Chai C; Sun F; Xia S; Shen W J Comput Assist Tomogr; 2016; 40(3):419-23. PubMed ID: 26953768 [TBL] [Abstract][Full Text] [Related]
13. [The application of Tang MT; Zeng XY; Li Y; Sun HT; Liu SY; Yuan X; Lu W Zhonghua Yan Ke Za Zhi; 2021 Nov; 57(11):830-836. PubMed ID: 34743468 [No Abstract] [Full Text] [Related]
14. Dixon MRI-based quantitative parameters of extraocular muscles, intraorbital fat, and lacrimal glands for staging thyroid-associated ophthalmopathy. Pu XY; Chen L; Hu H; Wu Q; Jiang WH; Lu JL; Chen HH; Xu XQ; Wu FY Insights Imaging; 2024 Jun; 15(1):136. PubMed ID: 38853188 [TBL] [Abstract][Full Text] [Related]
15. [Clinical Analysis of 2 170 Cases of Thyroid-Associated Ophthalmopathy Involving Extraocular Muscles]. Yang M; Du BX; Wang YJ; He WM Sichuan Da Xue Xue Bao Yi Xue Ban; 2021 May; 52(3):510-515. PubMed ID: 34018373 [TBL] [Abstract][Full Text] [Related]
16. Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease. Lennerstrand G; Tian S; Isberg B; Landau Högbeck I; Bolzani R; Tallstedt L; Schworm H Acta Ophthalmol Scand; 2007 Mar; 85(2):192-201. PubMed ID: 17305734 [TBL] [Abstract][Full Text] [Related]
17. Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy. Yokoyama N; Nagataki S; Uetani M; Ashizawa K; Eguchi K Thyroid; 2002 Mar; 12(3):223-7. PubMed ID: 11952043 [TBL] [Abstract][Full Text] [Related]
18. Predicting the response to glucocorticoid therapy in thyroid-associated ophthalmopathy: mobilizing structural MRI-based quantitative measurements of orbital tissues. Hu H; Xu XQ; Chen L; Chen W; Wu Q; Chen HH; Zhu H; Shi HB; Wu FY Endocrine; 2020 Nov; 70(2):372-379. PubMed ID: 32504380 [TBL] [Abstract][Full Text] [Related]
19. Correlation between magnetic resonance imaging and ultrasound measurements of eye muscle thickness in thyroid-associated orbitopathy. Karhanova M; Kovar R; Frysak Z; Sin M; Zapletalova J; Rehak J; Herman M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):307-12. PubMed ID: 24510024 [TBL] [Abstract][Full Text] [Related]
20. [Extraocular muscle involvement in patients with thyroid-associated orbitopathy]. Karhanová M; Kovář R; Fryšák Z; Zapletalová J; Marešová K; Sín M; Heřman M Cesk Slov Oftalmol; 2014 Apr; 70(2):66-71. PubMed ID: 25030316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]